GRAL - NASDAQ
GRAIL, Inc.
$66.93
+9.5%GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
At a Glance
Live SnapshotGRAIL, Inc. Management Team
Mr. Andrew John Partridge
Chief Commercial Officer
Mr. Robert P. Ragusa
Chief Executive Officer & Director
Compensation
$1,539,701
Mr. Aaron Freidin
Chief Financial Officer
Compensation
$817,800
Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng
Chief Scientific Officer & President International
Mr. Abram Barth J.D., M.P.H.
General Counsel
Dr. Joshua J. Ofman M.D., M.S.H.S
President
Compensation
$1,040,820
Sir Harpal S. Kumar M.A., M.B.A., MA, MBA, MEng
President of International Business & BioPharma
Dr. Eric T. Fung M.D., Ph.D.
Senior Vice President of Clinical Development
Mr. Paul Ciccolella
Senior Vice President of Global Development & Operations
Mr. Rodger Currie J.D.
Senior Vice President of Government Affairs
Ms. Alison Highlander
Senior Vice President of Human Resources & Head of People Team
Mr. Paul Ciccolella
Senior Vice President of Research, Development & Operations
GRAIL, Inc. Insider Positioning
During the last 12 months, insiders have sold $104.57M worth of GRAL shares, with no buying activity reported.
3 Months
0
0.00
233.4K
11.64M
-11.6M
-$11.64M
3-6 Months
0
0.00
1.4K
75.03K
-75K
-$75K
6-9 Months
0
0.00
1.1M
90.06M
-90.1M
-$90.06M
9-12 Months
0
0.00
60.3K
2.79M
-2.8M
-$2.79M
Top Buyers
No buying activity
Top Sellers
Illumina, Inc.
10 Percent Owner
$79.85M
Ofman Joshua J.
Director, Officer: President
$12.35M
Ragusa Robert P
Director, Officer: Chief Executive Officer
$8.06M
Freidin Aaron
Officer: Chief Financial Officer
$2.91M
Ding Chun R
10 Percent Owner
$1.40M
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $104.57M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
SEC Filings
GRAL - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | June 18, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 15, 2025 | May 29, 2025 | 2025 | |
DEF 14A DEF 14A 2025 N/A | April 15, 2025 | May 29, 2025 | 2025 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.